Multiple sclerosis: Cost of the disease;Sclérose en plaques: Coût de la maladie

Revue Neurologique

Volumn 157, Issue 8-9 II, 2001, Pages 1169-1174

  Tissot, E ^a   Woronoff Lemsi, M C ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON;

CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; DRUG COST; ECONOMIC ASPECT; HEALTH CARE SYSTEM; HUMAN; MEDICAL INFORMATION; MULTIPLE SCLEROSIS;

COST OF ILLNESS; COSTS AND COST ANALYSIS; CROSS-CULTURAL COMPARISON; DRUG COSTS; HEALTH EXPENDITURES; HOSPITAL COSTS; HUMANS; MULTIPLE SCLEROSIS;

EID: 0034790742     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Economic consequences of multiple sclerosis for Canadians
2. Impact social et économique de la sclérose en plaques
3. The economics of multiple sclerosis: A cost of illness study
4. Health care costs of veterans with multiple sclerosis: Implications for the rehabilitation of MS
5. Utilisation and cost of professional care and assistance according to disability of patients with multiple sclerosis in Flanderq (Belgium)
6. Economic assessment of the relationship between disease exacerbations and the cost of multiple sclerosis
7. The impact of new pharmaceutical agents on the cost of neurologic care
8. The economic cost of multiple sclerosis in Sweden in 1994
9. The cost of multiple sclerosis
10. Les répercussions économiques de la sclérose en plaques
11. Economic evaluation of multiple sclerosis in the UK, Germany and France
12. Alternative approaches to valuing intangible health losses: Evidence for multiple sclerosis
13. Health care utilization in multiple sclerosis. A population-based study in Olmsted County
14. A cost-of-illness study of multiple sclerosis from a hospital's perspective: Preliminary results
15. A comprehensive assessment of cost of multiple sclerosis in the United States